The Effects Of HMO On The Faecal Microbiota And On Gastrointestinal Symptoms In Healthy Volunteers

Inclusion Criteria: * Signed written informed consent * Ability and willingness to understand and comply to the study procedures Exclusion Criteria: * Participation in a clinical study one month prior to screening visit and throughout the study. * Abnormal results of the screening laboratory tests clinically relevant for study participation, as judged by the investigator. * Any gastrointestinal symptom scored \>3 on the GSRS during the screening period * A mean score on the total GSRS \>2 (i.e. above the population norm value) during the screening period * Any gastrointestinal disease(s) that may cause symptoms or may interfere with the trial outcome, as judged by the investigator. * Other severe disease(s) such as malignancy, diabetes, severe coronary disease, kidney disease or neurological disease, as judged by the investigator. * Severe psychiatric disease, as judged by the investigator. * Use of highly dosed probiotic supplements (yoghurt allowed) 3 months prior to the study and throughout the study. * Consumption of antibiotic drugs 3 months prior to screening and throughout the study. * Consumption on a regular basis of medication that might interfere with symptom evaluation (as judged by the investigator) 2 weeks prior to screening and throughout the study. * Pregnant or lactating or wish to become pregnant during the period of the study. * Lack of suitability for participation in the study for any reason as judged by the investigator.